Objective. The purpose of this work is to compare the long-term survival between a control group with mostly D1 lymphadenectomy and a study group with mostly D2 lymphadenectomy.
Introduction
Gastric cancer, despite having received intense scientific attention in terms of new therapeutic approaches and despite its decrease in incidence, continues to be an important cause of cancer related deaths (1, 2) . A review by He Most of the major differences still come from a difference of results (4) between Eastern and Western trials comparing the benefits of an extended lymphadenectomy. The demographic differences are most probably the best explanation for these differences -Western patients are on average 10 years older and have a higher incidence of comorbidities such as obesity and cardio-vascular disease that could account for the differences found in postoperative morbidity (5) . On the other hand, differences in technique could also account for the lack of homogeneity in terms of outcomes, especially when patients operated at different stages of the learning curve of the technique are included in the same study.
The aim of our study was to evaluate the differences in survival between two retrospectively selected groups of consecutive gastric cancer patients.
A control group of patients operated before the D2 lymphadenectomy technique was introduced as standard practice was compared to a study group of patients on whom the D2 lymphadenectomy was performed by a single senior surgeon experienced in the practice of this technique.
Materials and Methods
For the means of our study we used a control group, previously used in an article describing postoperative survival in gastric cancer patients (6 The differences in overall survival between the two study groups were assessed using univariate ANOVA. For the purpose of this study we considered acceptable a statistical significance level of 5%.
Results
Based on the data obtained from the Digital Data Base Population Registry, in the control group we were able to unequivocally identify 135 patients (94,4%) while in the study group the number of patients that we were able to positively identify was 47 (83,92%).
Demographic analysis
In both groups there was a male predominance with a proportion of 66,67% men in the control group and 57,44% men in the study group. In terms of age, in both groups the majority of patients were in their 6th
decade of life (Table 1) .
Tumour characteristics and survival
As can be seen in Table 1 In the control group we had no surviving patients five years after the surgical procedure, but in the study group 8 (20%) patients were alive after 60 months of follow-up. Within this subgroup of surviving patients there was 1 (12,5%) patient staged pN2 and 1 (12,5%) patient staged pN3, while the rest of 6 patients were equally distributed between the pN0 and pN1 stages.
Also, within this subgroup of survivors we found 5 (62,5%) patients with distally located tumors, 3 (37,5%) patients with tumors located within the middle third of the stomach and no patients with proximal tumors.
Oncologic quality of the gastric resection and the type of lymphadenectomy
The oncologic quality of the gastric resection was classified as R0 -no microscopic remnant neoplastic tissue or R1 -remnant cancer tissue, including both microscopic and macroscopic positive resection margins. In the control group we were able to compare the outcomes in terms of survival between R0
procedures, R1 procedures and simple laparotomies and found a statistically significant (p<0,05) difference in survival between these groups of patients, favoring radical procedures as can be seen from the survival Figure 2 . Such a comparison was not possible in the current study group due to the small number of patients that had an R1 resection (4 patients). We then proceeded to compare the survival of the patients with an R0 resection in the control group and that of the patients with an R0 resection in the study group and found significantly better survival intervals in the study group (p<0,001). The survival curves are plotted in Figure 3 and the difference in survival is clearly noticeable. A further step in our analysis was to compare the outcome following D2 lymphadenectomy in the control group versus the study group. In the study group a spleen preserving D2 lymphadenectomy was performed whenever possible and pancreatic preservation was the rule, except for cases where a pancreatic resection was required to achieve an R0
resection. An increase in the percentage of the D2 lymphadenectomy in the study group (85,1%, 40 patients) versus the control group (30,56%, 22 patients) was clearly visible. The survival curves of the patients that underwent D2 lymphadenectomy in the control and the study group are plotted in Figure 4 with a clearly visible improvement in survival in the study group. An ANOVA analysis also revealed a statistically significant (p<0,001) increase in the survival of patients with D2 lymphadenectomy in the study group compared to the control group. 
Discussions
Our study has shown an improvement in survival in the study group compared to the control group. Such a difference could be explained by the fact that patients in the study group presented in earlier stages of the disease, the indications for surgery were strictly respected in accordance with current international guidelines and the D2 lymphadenectomy in the study group has been performed by a single surgeon whose experience is located on the plateau of the learning curve, ensuring homogeneity from the point of view of the surgical technique.
As expected, we found that the highest incidence in both groups was during the 6th decade of life, while the sex distribution revealed a higher incidence in male patients, with higher male to female ratio in the control group of patients compared to the study group (Table   1) . A noteworthy difference between the two groups was the fact that in the control group we found a high Our study does not aim to compare the D1 and D2
lymphadenectomy procedures but only to compare the survival differences between a group of patients with D2 lymphadenectomy operated by several surgeons in our center whose level of experience was located at different points on the learning curve and a second group of patients operated by a single senior surgeon whose experience in performing D2 lymphadenectomy is placed on the plateau of the learning curve.
Collaterally we were also able to draw some conclusions regarding the differences in the survival of the patients based on parameters such as stage of the tumor, extent of the surgical procedure and the curative vs. palliative character of the procedure.
The comparison of the survival differences based on the type of resection (R0 vs R1) and the type of lymphadenectomy (D1 vs. D2) reveals significant differences. A significant increase in survival is clearly shown in Figure 3 between patients that had a curative resection in the control study group and those that had the same type of resection in the study group. A similar difference is also noticeable in Figure 4 between patients with D2 lymphadenectomy in the control study group and those with a D2 lymphadenectomy in the study group. The explanation could be that patients in the control group were operated by an inhomogeneous group of surgeons relative to their experience, most of them still in the process of learning the D2 lymphadenectomy procedure, while the study group is operated by a surgeon who has an experience level located on the plateau of the learning curve. A possible explanation could also be that the spleen preservation was achievable in most of the patients of the study group -38 (80,85%) patients, and pancreas preservation was possible in all patients. A comparison of survival between patients with and without splenectomy in the study group revealed no statistically significant differences in survival.
The quality of life of patients was not assessed and the cause of death was not specified in the Digital Data
Base Population Registry which is why we based our study on the overall survival of the patients in both groups.
Conclusions
A significant improvement in survival can be seen in patients undergoing D2 lymphadenectomy and R0 resections in the current study group compared to the control study group, due to the experience accumulated in performing the technique, correct preoperative staging and spleen and pancreas preservation strategies.
